Literature DB >> 2921359

Diurnal variations in serum biochemical and haematological measurements.

S J Pocock1, D Ashby, A G Shaper, M Walker, P M Broughton.   

Abstract

Twenty five biochemical and haematological measurements were determined on nonfasting blood and serum samples collected between 9 am and 7 pm from a representative group of 7685 British middle-aged men. Most measurements showed significant diurnal variations, but only for bilirubin, phosphate, and triglyceride did time of day account for more than 5% of the between subject variance. Serum bilirubin concentrations showed a pronounced downward trend in the afternoon, the mean value after 6 pm being 30% lower than the mean value in the morning. Mean serum triglyceride and phosphate concentrations increased steadily through the day. Mean concentrations of potassium, haemoglobin, and haematocrit and red cell count were higher in the morning, while urea and creatinine concentrations and white cell count had higher means in the afternoon. Glucose showed a pattern consistent with short term response to meals. The effects of these diurnal trends on routine use of biochemical tests needs careful consideration, and a greater understanding of their biological mechanisms is required.

Entities:  

Mesh:

Year:  1989        PMID: 2921359      PMCID: PMC1141821          DOI: 10.1136/jcp.42.2.172

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  18 in total

1.  Dietary fats and the diurnal serum triglyceride levels in man.

Authors:  P T KUO; J C CARSON
Journal:  J Clin Invest       Date:  1959-08       Impact factor: 14.808

2.  The effects of time of venipuncture on variation of serum constituents. Consideration of within-day and day-to-day changes in a group of healthy young men.

Authors:  P Winkel; B E Statland; H Bokelund
Journal:  Am J Clin Pathol       Date:  1975-10       Impact factor: 2.493

3.  The evaluation of white-cell counting in radiation protection.

Authors:  A C CHAMBERLAIN; F M TURNER; E K WILLIAMS
Journal:  Br J Radiol       Date:  1952-04       Impact factor: 3.039

4.  Factors contributing to intra-individual variation of serum constituents. 1. Within-day variation of serum constituents in healthy subjects.

Authors:  B E Statland; P Winkel; H Bokelund
Journal:  Clin Chem       Date:  1973-12       Impact factor: 8.327

5.  Intra-individual variation in commonly analyzed serum constituents.

Authors:  B Morrison; A Shenkin; A McLelland; D A Robertson; M Barrowman; S Graham; G Wuga; K J Cunningham
Journal:  Clin Chem       Date:  1979-10       Impact factor: 8.327

6.  Long-term trends in biochemical data obtained from two population surveys.

Authors:  P M Broughton; R Holder; D Ashby
Journal:  Ann Clin Biochem       Date:  1986-07       Impact factor: 2.057

7.  Circadian rhythms of blood minerals in humans.

Authors:  M Markowitz; L Rotkin; J F Rosen
Journal:  Science       Date:  1981-08-07       Impact factor: 47.728

8.  Total cholesterol, high density lipoprotein-cholesterol and triglycerides after a standardized high-fat meal.

Authors:  D S Thelle; D G Cramp; I Patel; M Walker; J W Marr; A G Shaper
Journal:  Hum Nutr Clin Nutr       Date:  1982

9.  British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns.

Authors:  A G Shaper; S J Pocock; M Walker; N M Cohen; C J Wale; A G Thomson
Journal:  Br Med J (Clin Res Ed)       Date:  1981-07-18

10.  The effect of age, sex and other factors on blood chemistry in health.

Authors:  K McPherson; M J Healy; F V Flynn; K A Piper; P Garcia-Webb
Journal:  Clin Chim Acta       Date:  1978-03-15       Impact factor: 3.786

View more
  31 in total

Review 1.  Haematocrit: within-subject and seasonal variation.

Authors:  Poul Thirup
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

2.  Active middle-aged men have lower fasting inflammatory markers but the postprandial inflammatory response is minimal and unaffected by physical activity status.

Authors:  Natalie C Dixon; Tina L Hurst; Duncan C S Talbot; Rex M Tyrrell; Dylan Thompson
Journal:  J Appl Physiol (1985)       Date:  2009-05-07

Review 3.  Factors affecting hemoglobin measurement.

Authors:  Lauren Berkow
Journal:  J Clin Monit Comput       Date:  2013-03-26       Impact factor: 2.502

4.  Role of risk factors for major coronary heart disease events with increasing length of follow up.

Authors:  S G Wannamethee; A G Shaper; P H Whincup; M Walker
Journal:  Heart       Date:  1999-04       Impact factor: 5.994

5.  Noninvasive glucose monitoring: a novel approach.

Authors:  Ilana Harman-Boehm; Avner Gal; Alexander M Raykhman; Jeffrey D Zahn; Eugene Naidis; Yulia Mayzel
Journal:  J Diabetes Sci Technol       Date:  2009-03-01

6.  The effect of fasting on total serum bilirubin concentrations.

Authors:  B H Meyer; H E Scholtz; R Schall; F O Müller; H K Hundt; J S Maree
Journal:  Br J Clin Pharmacol       Date:  1995-02       Impact factor: 4.335

7.  Bilirubin-a potential marker of drug exposure in atazanavir-based antiretroviral therapy.

Authors:  Dinko Rekić; Oskar Clewe; Daniel Röshammar; Leo Flamholc; Anders Sönnerborg; Vidar Ormaasen; Magnus Gisslén; Angela Abelö; Michael Ashton
Journal:  AAPS J       Date:  2011-09-13       Impact factor: 4.009

8.  External validation of the bilirubin-atazanavir nomogram for assessment of atazanavir plasma exposure in HIV-1-infected patients.

Authors:  Dinko Rekić; Daniel Röshammar; Martin Bergstrand; Joel Tarning; Andrea Calcagno; Antonio D'Avolio; Vidar Ormaasen; Marie Vigan; Aurélie Barrail-Tran; Michael Ashton; Magnus Gisslén; Angela Äbelö
Journal:  AAPS J       Date:  2012-12-07       Impact factor: 4.009

Review 9.  Is there an association between low dose aspirin and anemia (without overt bleeding)? Narrative review.

Authors:  Helen Gaskell; Sheena Derry; R Andrew Moore
Journal:  BMC Geriatr       Date:  2010-09-29       Impact factor: 3.921

Review 10.  The use of fibroblast growth factor 23 testing in patients with kidney disease.

Authors:  Edward R Smith
Journal:  Clin J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.